Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-034190

SVP & General Counsel sold 1,917 shares at $18.30 ($35,081)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2021-05-17 Sale −1,917 $18.30 $35,081 74,810 D
Open-market sales · 1,917 sh · avg $18.30 · $35,081
Loading xslF345X03/doc4.xml…